Lancet[journal] 检索结果

3541. The importance of a healthy mouth in Parkinson's disease.

作者: Merel C Verhoeff.;Henk W Berendse.;Frank Lobbezoo.
来源: Lancet. 2023年402卷10411期1419-1420页

3542. The impact of the 4th CAANS congress on neurosurgery in Africa.

作者: Edwin K Mogere.
来源: Lancet. 2023年402卷10411期1417-1418页

3543. A simple research framework will improve mass casualty responses.

作者: Simon Horne.;Paul Hunt.;Ben Hall.;Sophie Jefferys.;James Vassallo.;Ian Gurney.
来源: Lancet. 2023年402卷10411期1417页

3544. Lessons from mine action: integrated care for civilians in conflict.

作者: Hannah Wild.;Adam Kushner.;Christelle Loupforest.;Barclay Stewart.
来源: Lancet. 2023年402卷10411期1416-1417页

3545. Civil disobedience labelled as antisocial personality disorder.

作者: Artin A Mahdanian.;Robert van Voren.;Rob Keukens.;Dainius Puras.
来源: Lancet. 2023年402卷10411期1415-1416页

3546. Iran must stop the use of pellets to target and blind protesters.

作者: Rohini Haar.;Ranit Mishori.;Saman Zia-Zarifi.
来源: Lancet. 2023年402卷10411期1415页

3547. Machines and empathy in medicine.

作者: Eric J Topol.
来源: Lancet. 2023年402卷10411期1411页

3548. Offline: "I have no place to go".

作者: Richard Horton.
来源: Lancet. 2023年402卷10411期1405页

3549. Complement inhibitors for the treatment of geographic atrophy.

作者: Emily Y Chew.
来源: Lancet. 2023年402卷10411期1396-1398页

3550. Understanding global gun violence, and how to control it.

作者: The Lancet.
来源: Lancet. 2023年402卷10411期1393页

3551. A decolonised Commission agenda: the missing ingredients - Author's reply.

作者: Valerie Percival.;Ben Oppenheim.;Oskar T Thoms.;Carolyn Chisadza.
来源: Lancet. 2023年402卷10414期1748-1750页

3552. A decolonised Commission agenda: the missing ingredients.

作者: Ramya Kumar.;Neil Arya.
来源: Lancet. 2023年402卷10414期1747-1748页

3553. Urgent humanitarian call to save lives in Gaza.

作者: Muhammad Abu Salmiya.
来源: Lancet. 2023年402卷10412期1523-1524页

3554. Risk of neoplasm with the neurokinin 3 receptor antagonist fezolinetant.

作者: Jonathan Douxfils.;Charlotte Beaudart.;Jean-Michel Dogné.
来源: Lancet. 2023年402卷10413期1623-1625页

3555. Insights from the nearest Israeli hospital to the Gaza Strip.

作者: Gili Givaty.;Yaniv S Ovadia.;Mor Saban.
来源: Lancet. 2023年402卷10412期1521-1522页

3556. Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial.

作者: David Russell-Jones.;Tetsuya Babazono.;Roman Cailleteau.;Susanne Engberg.;Concetta Irace.;Maiken Ina Siegismund Kjaersgaard.;Chantal Mathieu.;Julio Rosenstock.;Vincent Woo.;David C Klonoff.
来源: Lancet. 2023年402卷10413期1636-1647页

ONWARDS 6 compared the efficacy and safety of once-weekly subcutaneous insulin icodec (icodec) and once-daily insulin degludec (degludec) in adults with type 1 diabetes.

3557. The global plastics treaty: why is it needed?

作者: Philip Landrigan.;Christos Symeonides.;Hervé Raps.;Sarah Dunlop.
来源: Lancet. 2023年402卷10419期2274-2276页

3558. Weekly insulin: a paradigm shift in type 1 diabetes therapy.

作者: Amy S Shah.;Risa M Wolf.
来源: Lancet. 2023年402卷10413期1598-1599页

3559. Moving cholera vaccines ahead of the epidemic curve.

作者: Ziad A Memish.;Lucille Blumberg.;Amal Saif Al-Maani.;Rama Baru.;Eve Dube.;George F Gao.;Daniel B Jernigan.;Yee-Sin Leo.;Joseph Sriyal Malik Peiris.;Jakir Hossain B Masud.;Jodie McVernon.;Justice Nonvignon.;Folasade Tolulope Ogunsola.;Helen Reese.;Rana Muhammad Safdar.;Kumnuan Ungchusak.;Lothar H Wieler.;David Heymann.
来源: Lancet. 2024年403卷10422期127-129页

3560. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.

作者: Alexander C Ford.;Alexandra Wright-Hughes.;Sarah L Alderson.;Pei-Loo Ow.;Matthew J Ridd.;Robbie Foy.;Gina Bianco.;Felicity L Bishop.;Matthew Chaddock.;Heather Cook.;Deborah Cooper.;Catherine Fernandez.;Elspeth A Guthrie.;Suzanne Hartley.;Amy Herbert.;Daniel Howdon.;Delia P Muir.;Taposhi Nath.;Sonia Newman.;Thomas Smith.;Christopher A Taylor.;Emma J Teasdale.;Ruth Thornton.;Amanda J Farrin.;Hazel A Everitt.; .
来源: Lancet. 2023年402卷10414期1773-1785页

Most patients with irritable bowel syndrome (IBS) are managed in primary care. When first-line therapies for IBS are ineffective, the UK National Institute for Health and Care Excellence guideline suggests considering low- dose tricyclic antidepressants as second-line treatment, but their effectiveness in primary care is unknown, and they are infrequently prescribed in this setting.

结果排序

文献格式

出版时间

出版类型

出版语言